Bulgaria's MFG invests in healthcare startup FindMeCure

The round was led by US investment company Techstars and angel investors, MFG said in a bourse filing.

FindMeCure is focused on building a bridge between patients and innovative treatments. The company is developing two healthcare platforms. The first one, named FindMeCure for Patients, provides information about ongoing clinical trials worldwide as well as alternative treatment approaches. The goal is to support patients in joining clinical trials or gaining access to other types of treatment.

The second platform, called Trialhub, is also in the area of clinical trials but is designed for business users. The solution facilitates finding information and planning clinical studies. The platform is currently offered in 70 countries and is used by companies conducting clinical trials such as ICON, Medpace, Novartis and Premier.

MFG Invest raised 4.04 million levs ($2.24 million/2.07 million euro) in an initial public offering in December.

($ = 0.9199 euro)